N itric oxide is a free radical gas synthesized from l-arginine by NO synthase (NOS). 1 Three different NOS isoforms have been isolated and cloned in human cells. Neural 2, 3 and endothelial NOS (NOS-1 and NOS-3, respectively) are constitutively expressed, 4 -7 whereas NOS-2 is induced by lipopolysaccharides (LPS) and cytokines in hepatocytes, 8, 9 chondrocytes, 10 vascular smooth muscle cells (VSMC), 11 monocytes, [12] [13] [14] [15] and other cells. 16, 17 Constitutive endothelial NOS has been reported to be a major regulator of arterial tone 18, 19 and catalyzes the release of picomoles of NO in response to endothelial cell stimulation by bradykinin, acetylcholine, and calcium ionophore. 20 The inducible NOS is considered less likely to be involved in the physiologic regulation of vessel tone. Indeed, induction of NOS in VSMC and monocytes by LPS and cytokines results in a large production of NO that is responsible for the pathologic vasorelaxation of endotoxic shock. after induction in animal models. 22 Moreover, recent data suggested an interaction between endothelial hormones and NO, whereas endothelin-1 enhances NO-induced cytotoxicity in VSMC 23 and endothelium derived NO release in renal vessels. 24 Angiotensin II has also been shown to interact with the NO pathway. 25 Furthermore, lipid deposits in arteriosclerosis has been associated with the induction of the NOS-2. 26 However, at present it is not clear whether human endothelial cells produce the NOS-2 after induction. The aim of the present work was to study human endothelial cell and monocyte NOS-2 and NOS-3 mRNA expression in response to vasoactive hormones by the reverse transcription polymerase chain reaction (RT-PCR). Electron paramagnetic resonance spectroscopy (EPR) was used to detect NO production in endothelial cells and monocytes, both under basal conditions and after vasoactive stimuli.
METHODS
Subjects Peripheral blood (40 mL) was drawn from 24 normotensive subjects, aged from 26 to 40 years, after informed consent. Umbilical cords were obtained from 10 healthy normotensive women after physiologic pregnancy and spontaneous delivery. Hepatocytes were obtained from two patients who underwent liver biopsy for diagnostic reasons. Procedures were approved by our ethical committee.
Cell Separation Peripheral blood monocytes were obtained as previously described. 27 Briefly, mononuclear cells were separated on Ficoll Hypaque (Lymphoprep, Nycomed Pharma, Oslo, Norway), resuspended in RPMI 1640 medium (Hy Clone Laboratories, Logan, UT) supplemented with 10% fetal calf serum (FCS). Cells (3 ϫ 10 6 cells/mL) were left to adhere for 2 h at 37°C on 25 cm 2 flasks after which nonadherent cells were discarded. Cell purity was Ͼ90% as determined by immunofluorescence staining of adherent cells with anti-CD14 (anti-human LeuM3, Becton-Dickinson, San Jose, CA) and anti-CD3/CD19 (anti-human Leu4/12, Becton Dickinson) and labeled cells were analyzed in a FAC scan (Becton Dickinson).
Human umbilical vein endothelial cells (HUVEC) were obtained by treating the cord vein with collagenase (Sigma, St. Louis, MO) 10 Ϫ5 mol/L and grown to confluence in 75 cm 2 plastic flasks in Iscove's medium (Hy Clone Europe, Cramlingtone) containing 20% FCS, penicillin (10 Ϫ4 UI/mL, GIBCO BRL, Paislay, UK), and streptomycin (6 ϫ 10 Ϫ3 mol/L, GIBCO BRL) as described previously.
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Cell Culture Purified monocytes (5 ϫ 10 5 cells/mL) were incubated for 4 h at 37°C in 10 mL of RPMI 1640 supplemented with 10% FCS, penicillin (10 Ϫ4 UI/mL), and streptomycin (6 ϫ 10 Ϫ3 mol/L) in the absence or presence of 100 UI/mL ␥IFN (Boehringer Mannheim, Mannheim, Germany),10 ng/mL LPS (Sigma),
Ϫ9 mol/L endothelin-1 (Peninsula Laboratories, Belmont, CA), 10 Ϫ15 mol/L angiotensin II (Sigma), 2 ϫ 10 Ϫ9 mol/L bradykinin (Peninsula Laboratories), or 3 ϫ 10 Ϫ8 mol/L cortisol (Sigma). In some cases, cells were preincubated in the presence of 0.5 mmol/L N-methyl-l-arginine (L-NMMA) 0.5 mmol/L (Sigma). HUVEC were grown to confluence in 25 cm 2 flasks in 10 mL Iscove medium and incubated for 4 h at 37°C with the same stimuli. Hepatocytes were incubated for 4 h at 37°C in the presence of LPS/␥IFN at the concentrations described above or immediately frozen at Ϫ80°C after collection until RNA extraction was performed. Each stimulation experiment was performed at least three times.
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
After incubation with different stimuli, monocytes and HUVEC were washed with physiologic saline. One milliliter of RNA FAST (Molecular System, San Diego, CA) was added and cells lysates were collected in Eppendorf tubes and frozen at Ϫ80°C. Total RNA was extracted and reverse transcription was performed using 1 g of total RNA, according to the manufacturer's instructions (Promega, Madison, WI). This method allows the isolation of undegraded, free of protein and DNA contamination, total RNA, without additional treatment with DNase. PCR was carried out in an automated DNA thermal cycler (Perkin Elmer, Foster City, CA) using specific primers: NOS-2 sense (5Ј-GTG AGG ATC AAA AAC TGG GG-3Ј), NOS-2 antisense (5Ј-ACC TGC AGG TTG GAC CAC-3Ј), NOS-3 sense (5Ј-ACA TGT TTG TCT GCG GCG-3Ј), NOS-3 antisense (5Ј-GCA (G/A)GG AAA AGC TCT GGGT-3Ј), 18 ␤-actin sense (5Ј-AGC GGG AAA TCG TGC GTG-3Ј), ␤-actin antisense (5Ј-CAG GGT ACA TGG TGC GTG-3Ј). 14 The PCR conditions were: 94°C 1 min, 60°C 1 min, 72°C 1 min for 30 cycles. PCR products were analyzed by 1.5% agarose gel electrophoresis. The NOS-2 PCR products obtained from monocytes were transferred to nylon filters (GeneScreen Plus, DuPont NEN, Boston, MA) and hybridized with a specific NOS-2 nested oligonucleotide (5Ј-TGG ATC CTC CCA ATG CAG CG -3Ј), end-labeled by T4 kinase (DuPont NEN) with [␥-32 P]ATP (DuPont NEN). A specific activity of 4 ϫ 10 6 cpm/mL was added to the hybridizing solution (5ϫ SSPE 0.5ϫ SDS 5ϫ Denhardt's) and the filters were incubated for 2 h at 42°C. Filters were then washed twice in 2ϫ SSPE at room temperature and once in 5ϫ SSPE at 52°C and exposed for 24 to 48 h at Ϫ80°C.
EPR Analysis of NO Production
The EPR allows the measurement and quantification of molecules with unpaired electrons such as free radicals. 29 Heme ironmononitrosyl complexes have been proposed as stable NO traps suitable for measuring NO in living tissues. 30, 31 In monocytes and HUVEC we observed the formation of these complexes, resulting from NO binding to the heme iron of the deoxyhemoglobin derived from erythrocytes, which have been extensively studied as a marker for the generation of NO in vitro biologic models. 32, 33 To provide deoxyhemoglobin to act as a trap for NO, hypotonic lysis of contaminant erythrocytes was not completely performed. An excess of hemoglobin was always present in all the samples, thus allowing to exclude that variable amounts of this trapping agent could account for differences among them. Monocytes and HUVEC (2 ϫ 10 6 /mL) were then incubated for 4 h at 37°C with epinephrine (range, 1 ϫ 10 Ϫ10 to 100 ϫ 10 Ϫ10 mol/L), endothelin-1 (range, 1 ϫ 10 Ϫ9 to 100 ϫ 10 Ϫ9 mol/L), angiotensin II (range, 1 ϫ 10
and bradykinin (range, 1 ϫ 10 Ϫ9 to 2 ϫ 10 Ϫ6 mol/L). The cellular response was then stopped by incubation on ice and after washing and centrifugation, pellets were transferred to 3-mm inner diameter EPR quartz tubes (Wilmad, Buena, NJ) and frozen in liquid nitrogen. EPR measurements were performed at 77 K in a quartz Dewar flask with 5-mm inner diameter. EPR spectra were recorded on a Bruker ESP-300E spectrometer operating at X-band with a 100-KHz modulation frequency and equipped with a rectangular TE102 cavity. Instrument settings were as follows: 9.39 to 0.41 GHz microwave frequency, 10 mW microwave power, 1 Gauss modulation amplitude, and 163.84 msec time constant. Background was recorded in the absence of cells using sam- 
FIGURE 2. Expression of NOS-2 mRNA and NOS-3 mRNA in HUVEC. NOS-2 (a), NOS-3 (b), ␤-actin (c). Unstimulated HUVEC (lane 1); HUVEC stimulated with epinephrine (lane 2); with dopamine (lane 3); with endothelin-1 (lane 4); with angiotensin II (lane 5); with bradykinin (lane 6); and with cortisol (lane 7).
ples containing reagents alone. All spectra were time averaged over four scans.
RESULTS

NOS-2 and NOS-3 mRNA Expression in Monocytes,
Hepatocytes, and HUVEC RT-PCR amplified a NOS-2 380-base pair (bp) fragment and a NOS-3 213-bp fragment. NOS-2 mRNA was not basally detectable in monocytes and HUVEC (Figure 1a ), whereas it was basally expressed in hepatocytes. After LPS/␥IFN stimuli, NOS-2 mRNA expression was induced in monocytes and was increased in hepatocytes ( Figure 1a ). In addition, NOS-3 mRNA was detectable in monocytes, hepatocytes, and HUVEC (Figure 1b ).
NOS-2 and NOS-3 mRNA Expression in HUVEC
Our results showed that NOS-2 expression was not detectable under basal conditions in HUVEC but was induced by vasoactive stimuli, such as epinephrine, dopamine, and endothelin-1. In contrast, angiotensin II, bradykinin, and cortisol did not induce NOS-2 expression (Figure 2a ). NOS-3 was expressed under basal conditions in HUVEC and was not modified by vasoactive stimuli (Figure 2b ). Cortisol was used as a known inhibitor of NOS-2 mRNA expression.
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NOS-2 and NOS-3 mRNA Expression in Monocytes
We were able to detect NOS-2 mRNA expression using RT-PCR in 9 of 14 monocyte samples, in the other 5 samples this expression was barely detectable under basal conditions (Figure 3a and d) . Epinephrine and dopamine (Figure 3a) , as well as endothelin 1 and 
FIGURE 4. Autoradiography of NOS-2 PCR products hybridized with a nested oligonucleotide 32 P end-labeled by a T4 kinase reaction. Unstimulated monocytes (lanes 1, 4); monocytes stimulated with epinephrine (lanes 2, 5); monocytes stimulated with dopamine (lanes 3, 6).
angiotensin II (Figure 3d) , induced or increased the basal expression in all cases. Bradykinin did not induce NOS-2 mRNA expression ( Figure 3d) ; cortisol was used as a known inhibitor. As with HUVEC, monocytes expressed NOS-3 mRNA under basal conditions and this expression was unaffected by vasoactive stimuli (Figure 3b and e) . Southern blotting and hybridization with 32 P-labeled nested oligonucleotide of lanes 1 to 6 of the gel shown in Figure 3a showed that the 380-bp fragment amplified by PCR is specific for NOS-2 mRNA (Figure 4) . In five cases, RT-PCR followed by gel electrophoresis failed to demonstrate (lanes 1, 4, 7, 10, 13), monocytes stimulated with endothelin-1 (lanes 2, 5, 8, 11, 14) , monocytes stimulated with angiotensin II (lanes 3, 6, 9, 12 ). HUVEC (1b, 2b, 3b, 4b); HUVEC  stimulated with epinephrine (1a), with angiotensin II (2a), with endothelin-1 (3a), and with bradykinin (4a) .
FIGURE 6. EPR spectra in HUVEC. For any given resonance absorption there is a characteristic spectroscopic splitting factor (g value). Triplet features at g ϭ 2.02 as well as peaks at g ϭ 2.07 to 2.08 are indicative of the formation of heme iron-mononitrosyl complexes, resulting from NO binding to the heme iron of deoxyhemoglobin present in varying amounts in our samples. After baseline normalization, the area under three line peaks was calculated by integrating EPR signals and the height of single line peaks at g ϭ 2.07 and g ϭ 2.08 was determined. In both cases results were expressed in arbitrary units. Unstimulated
amplification of a NOS-2 fragment (data not shown); in these cases the agarose gel was blotted onto a nylon filter and hybridized with the nested oligonucleotide, as described previously, to increase the sensitivity of detection. Figure 5 shows the detection of a band of the expected size in four of five cases, and NOS-2 expression appears to be induced by endothelin-1 and angiotensin II.
EPR Analysis in HUVEC Typical EPR spectra for nitrosyl-hemoglobin derivatives were detected in HUVEC after epinephrine, angiotensin II, and endothelin-1 stimuli, confirming that the RNA message is followed by enzyme and NO production ( Figure 6 ). Resulting signals in our experiments showed the characteristic three-line hyperfine pattern centered at g ϭ 2.02 (g is the spectroscopic splitting factor specific for each molecule), with two additional peaks at g ϭ 2.08 and g ϭ 2.07. 30 Bradykinin was used as a positive control in these experiments. Relative quantification of signal intensity was performed by double integration of first derivative spectra for the comparison among different triplet patterns, whereas the height-to-baseline values, which reflect the intensity of absorption, were calculated for single line EPR peaks. Results were expressed in each cases as arbitrary units and are reported in Table 1 . After epinephrine and angiotensin II treatment with doses in the physiologic range, we observed a strong increase in NO production, whereas endothelin-1 produced a significant response only for supraphysiologic concentrations. In each case, the preincubation with L-NMMA abolished the induced NO production. A dose-response correlation was found for each stimuli (Figure 7 ).
EPR Analysis in Monocytes
When performed on monocytes, EPR analysis showed the characteristic peaks at g ϭ 2.02 of heme-iron-mononitrosyl complexes formation after epinephrine, endothelin-1, angiotensin II, and LPS/␥IFN stimuli (Figure 8) , in the concentration range described previously. The results of quantitative analysis of EPR signals in monocytes are shown in Table 1 and Figure 7 .
DISCUSSION
We showed that human monocytes and HUVEC express constitutively NOS-3 mRNA. In both cell types, vasoactive hormones did not modify NOS-3 mRNA expression. NOS-2 mRNA expression was induced in human hepatocytes after LPS and ␥IFN addition, confirming previous observations. 8, 9 Interestingly, in most cases RT-PCR with specific oligonucleotides was able to detect NOS-2 mRNA expression in monocytes; a higher sensitivity was achieved after hybridization with a 32 P-labeled nested oligonucleotide. We observed that epinephrine, dopamine, endothelin-1, and angiotensin II induced NOS-2 mRNA expression in these cells. Accordingly, NO production, studied by EPR analysis, was enhanced in monocytes after epinephrine, endothelin-1, angiotensin II, and LPS/␥IFN stimulation. Moreover, our findings indicated that HUVEC express NOS-2 mRNA after epinephrine, dopamine, and endothelin-1, but not after angiotensin II treatment. On the other hand, a comparable increase in NO production was detected by EPR analysis with all stimuli. The effect of endothelin-1, however, was evident only at concentrations above the physiologic range; we speculate that as endothelin-1 acts as a paracrine factor, the normal plasmatic concentration may be suboptimal. A dose-dependent effect on NO production was observed in EPR for epinephrine, angiotensin II, and endothelin-1; a dose-dependent NOS-2 mRNA production was observed in monocytes after epinephrine and dopamine stimuli, despite the fact that RT-PCR is only a semiquantitative assay (data not shown).
The pattern of NOS-2 mRNA expression in monocytes and HUVEC was almost overlapping, consistent with a possible role of monocytes in the regulation of vascular tone. However, an exception was with angiotensin II, which increased NOS-2 mRNA expression in monocytes, but not in HUVEC. Nevertheless, NO production in HUVEC was detectable by EPR after angiotensin II stimulation. Moreover, recent reports showed that angiotensin II upregulates NO production from NOS-2 in rat cardiac myocytes and carotid arteries. 35, 36 Our findings suggest a possible involvement of vasoactive hormonal substances in the modulation of NO synthesis in both HUVEC and monocytes, supporting previous studies on the link between endothelial dysfunction and monocyte-macrophage infiltration in rats with hypertension. 37 These results indicate that very low amounts of NOS-2 mRNA are expressed in monocytes and endothelial cells after appropriate stimuli and this expression is followed by NO production. We suggest that besides NOS-3, monocyte and endothelial NOS-2 may produce NO in low amounts and this production may have a role in the physiologic regulation of arterial tone. Endothelial cell and monocyte NOS-2 may release NO in response to vasoconstrictor hormones, such as epinephrine, dopamine, endothelin-1, and angiotensin II, and the NO production that occurs after these stimuli may represent a physiologic counterregulation. Indeed, this mechanism may contribute to the increased NO production found under pathologic conditions, in which the sympathetic system is activated, such as in heart failure 38 and hepatorenal syndrome. 39 Moreover, an enhanced NO synthesis, as a consequence of the induction of this pathway, is likely to occur also in syndromes characterized by vasospastic episodes, including myocardial angina, migraine attacks, and Raynaud's phenomenon. 40 Previous studies demonstrated that endothelium-dependent relaxation is decreased in patients with essential hypertension, 41 suggesting that impaired generation of NO may contribute to the development of the disease. 42 NOS expression and NO production in human subjects has not been well defined. We have shown that molecular biologic analyses coupled with the application of EPR spectroscopy may represent a suitable approach to investigate cellular responses. Moreover, our experimental model might be a valuable tool for the study of the effects of pharmacologic treatments, ie, with angiotensin converting enzyme inhibitors or endothelin antagonists, on cellular responses.
